Display options
Share it on

Sci Data. 2017 Jul 19;4:170091. doi: 10.1038/sdata.2017.91.

Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer.

Ehwang Song, Yuqian Gao, Chaochao Wu, Tujin Shi, Song Nie, Thomas L Fillmore, Athena A Schepmoes, Marina A Gritsenko, Wei-Jun Qian, Richard D Smith, Karin D Rodland, Tao Liu

Affiliations

  1. Biological Sciences Division, Richland, WA 99354, USA.
  2. Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA 99354, USA.

PMID: 28722704 PMCID: PMC5516542 DOI: 10.1038/sdata.2017.91

Abstract

Mass spectrometry (MS) based targeted proteomic methods such as selected reaction monitoring (SRM) are emerging as a promising tool for verification of candidate proteins in biological and biomedical applications. The Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the National Cancer Institute has investigated the standardization and analytical validation of the SRM assays and demonstrated robust analytical performance on different instruments across different laboratories. An Assay Portal has also been established by CPTAC to provide the research community a resource consisting of large sets of targeted MS-based assays, and a depository to share assays publicly. Herein, we report the development of 98 SRM assays that have been thoroughly characterized according to the CPTAC Assay Characterization Guidance Document; 37 of these passed all five experimental tests. The assays cover 70 proteins previously identified at the protein level in ovarian tumors. The experiments, methods and results for characterizing these SRM assays for their MS response, repeatability, selectivity, stability, and endogenous detection are described in detail. Data are available via PeptideAtlas, Panorama and the CPTAC Assay Portal.

References

  1. Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15395-400 - PubMed
  2. Proteomics. 2017 Mar;17 (6):null - PubMed
  3. Mol Cell Proteomics. 2014 Mar;13(3):907-17 - PubMed
  4. Biomark Insights. 2007 Feb 07;1:1-48 - PubMed
  5. Mol Cell Proteomics. 2015 Feb;14(2):430-40 - PubMed
  6. Nat Biotechnol. 2009 Jul;27(7):633-41 - PubMed
  7. Bioanalysis. 2013 Feb;5(3):267-9 - PubMed
  8. Clin Chem. 2016 Jan;62(1):48-69 - PubMed
  9. BMC Med. 2014 Sep 11;12:156 - PubMed
  10. J Proteomics. 2012 Aug 3;75(15):4747-57 - PubMed
  11. Nat Methods. 2012 May 30;9(6):555-66 - PubMed
  12. Nature. 2014 May 29;509(7502):582-7 - PubMed
  13. Cancer. 1993 Apr 1;71(7):2204-9 - PubMed
  14. J Cell Sci. 2003 Aug 1;116(Pt 15):3051-60 - PubMed
  15. Mol Cell Proteomics. 2013 Dec;12(12):3444-52 - PubMed
  16. Clin Chem. 2014 Mar;60(3):541-8 - PubMed
  17. Bioinformatics. 2004 Jun 12;20(9):1466-7 - PubMed
  18. Nat Biotechnol. 2015 Sep;33(9):990-5 - PubMed
  19. BMC Bioinformatics. 2012;13 Suppl 16:S9 - PubMed
  20. Trends Pharmacol Sci. 2014 Apr;35(4):178-86 - PubMed
  21. EMBO Rep. 2008 May;9(5):429-34 - PubMed
  22. Nat Methods. 2014 Jul;11(7):703-4 - PubMed
  23. Proteomics. 2016 Aug;16(15-16):2160-82 - PubMed
  24. Biochim Biophys Acta. 2017 May;1865(5):488-498 - PubMed
  25. Am J Clin Pathol. 1997 Apr;107(4):451-8 - PubMed
  26. Methods Mol Biol. 2016;1410:223-36 - PubMed
  27. Cancer Biol Ther. 2009 Jun;8(12):1083-94 - PubMed
  28. Cancer Discov. 2013 Oct;3(10):1108-12 - PubMed
  29. J Proteome Res. 2015 Jun 5;14(6):2707-13 - PubMed
  30. Cancer. 1994 Sep 15;74(6):1693-8 - PubMed
  31. Bioinformatics. 2010 Apr 1;26(7):966-8 - PubMed
  32. Mol Cell Proteomics. 2002 Nov;1(11):845-67 - PubMed
  33. J Proteome Res. 2010 Feb 5;9(2):761-76 - PubMed
  34. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14440-5 - PubMed
  35. Nat Methods. 2010 Jan;7(1):43-6 - PubMed
  36. Biochemistry. 2013 Jun 4;52(22):3797-806 - PubMed
  37. Mol Cell Proteomics. 2011 Nov;10(11):M110.003384 - PubMed
  38. Mol Syst Biol. 2008;4:222 - PubMed
  39. Cell. 2016 Jul 28;166(3):755-765 - PubMed
  40. Proteomics. 2004 Apr;4(4):1175-86 - PubMed
  41. Clin Chem. 2010 Feb;56(2):212-22 - PubMed
  42. Nature. 2014 May 29;509(7502):575-81 - PubMed
  43. Br J Cancer. 1995 Feb;71(2):357-62 - PubMed
  44. Cell. 2016 Jul 28;166(3):766-78 - PubMed
  45. Curr Protoc Protein Sci. 2001 May;Chapter 11:Unit 11.1 - PubMed

MeSH terms

Publication Types

Grant support